Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy
Mouen A. Khashab, Katherine J. Kim(Johns Hopkins University), E. Tryggestad(Johns Hopkins Hospital), Aaron T. Wild(Johns Hopkins University), Teboh Roland(Johns Hopkins University), Vikesh K. Singh(Johns Hopkins Hospital), Anne Marie Lennon(Johns Hopkins Hospital), Eun Ji Shin(Johns Hopkins Hospital), Mark A. Ziegler(Johns Hopkins University), Reem Z. Sharaiha(Johns Hopkins Hospital), Marcia Irene Canto(Johns Hopkins Hospital), Joseph M. Herman(Johns Hopkins Hospital)
Cited by 92
Abstract
Related Papers
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al.|Journal of Clinical Oncology|1997|5.9k
Cancer Statistics, 2001
Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al.|CA A Cancer Journal for Clinicians|2001|3.3k